Vol 79, Supp. IV (2021): Zeszyty Edukacyjne 4/2021
Opinie i stanowiska ekspertów
Published online: 2021-11-26

open access

Page views 6834
Article views/downloads 10758
Get Citation

Connect on Social Media

Connect on Social Media

Przezcewnikowa naprawa i wymiana zastawki mitralnej. Stanowisko Ekspertów Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Kardio-Torakochirurgów

Wojciech Wojakowski1, Zbigniew Chmielak2, Kazimierz Widenka3, Jerzy Pręgowski2, Bartłomiej Perek4, Andrzej Gackowski5, Krzysztof Bartuś6, Piotr Szymański7, Marek A. Deja8, Zbigniew Kalarus9, Piotr Suwalski10, Jarosław Trębacz11, Piotr Kołsut12, Piotr Ścisło13, Krzysztof Wróbel14, Grzegorz Smolka1, Witold Gerber15, Dariusz Dudek1617, Tomasz Hirnle18, Marek Grygier19, Stanisław Bartuś20, Adam Witkowski2, Mariusz Kuśmierczyk12
DOI: 10.33963/v.kp.87140

Abstract

Not available

References

  1. Petrus AHJ, Dekkers OM, Tops LF, et al. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J. 2019; 40(27): 2206–2214.
  2. Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020; 8(4): 265–276.
  3. Mehr M, Karam N, Taramasso M, et al. TriValve and TRAMI Investigators. Combined tricuspid and mitral versus isolated mitral valve repair for severe mr and TR: an analysis from the trivalve and TRAMI registries. JACC Cardiovasc Interv. 2020; 13(5): 543–550.
  4. Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019; 8(17): e013332.
  5. Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739–2791.
  6. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005; 46(11): 2134–2140.
  7. Feldman T, Foster E, Glower DD, et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364(15): 1395–1406.
  8. Mack MJ, Lindenfeld J, Abraham WT, et al. COAPT Investigators. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol. 2021; 77(8): 1029–1040.
  9. Feldman T, Kar S, Elmariah S, et al. EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015; 66(25): 2844–2854.
  10. Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018; 379(24): 2297–2306.
  11. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018; 379(24): 2307–2318.
  12. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging. 2019; 20(6): 620–624.
  13. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013; 62(12): 1052–1061.
  14. Kalbacher D, Schäfer U, V Bardeleben RS, et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. Int J Cardiol. 2019; 277: 35–41.
  15. Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016; 134(3): 189–197.
  16. Attizzani GF, Ohno Y, Capodanno D, et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc Interv. 2015; 8(1 Pt A): 74–82.
  17. Grasso C, Capodanno D, Scandura S, et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol. 2013; 111(10): 1482–1487.
  18. Horn P, Hellhammer K, Minier M, et al. Deep sedation vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip system. Catheter Cardiovasc Interv. 2017; 90(7): 1212–1219.
  19. Takagi H, Ando T, Umemoto T, et al. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. Int J Cardiol. 2017; 228: 289–294.
  20. Besler C, Noack T, von Roeder M, et al. Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series. EuroIntervention. 2020; 16(10): 824–832.
  21. Yeo KK, Yap J, Tan JW, et al. Venous access closure using the double-proglide preclose technique after mitraclip implantation: long-term clinical and duplex ultrasound outcomes. J Invasive Cardiol. 2016; 28(2): 40–43.
  22. MitraClip provides valve repair without surgery. Harv Heart Lett. 2014; 24(6): 8.
  23. Schueler R, Öztürk C, Wedekind JA, et al. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. JACC Cardiovasc Interv. 2015; 8(3): 450–459.
  24. Morikawa T, Miyasaka M, Flint N, et al. Right-to-Left shunt through iatrogenic atrial septal defect after mitraclip procedure. JACC Cardiovasc Interv. 2020; 13(13): 1544–1553.
  25. Kadado AJ, Islam A. Iatrogenic atrial septal defect following the MitraClip procedure: A state-of-the-art review. Catheter Cardiovasc Interv. 2021; 97(7): E1043–E1052.
  26. Lurz P, Unterhuber M, Rommel KP, et al. Closure of iatrogenic atrial septal defect after transcatheter mitral valve repair: the randomized MITHRAS trial. Circulation. 2021; 143(3): 292–294.
  27. von Bardeleben RS, Hobohm L, Kreidel F, et al. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants. EuroIntervention. 2019; 14(17): 1725–1732.
  28. Isogai T, Saad AM, Shekhar S, et al. Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system. Catheter Cardiovasc Interv. 2021; 97(2): 335–341.
  29. Thomas F, Rader F, Siegel RJ. The use of MitraClip for symptomatic patients with hypertrophic obstructive cardiomyopathy. Cardiology. 2017; 137(1): 58–61.
  30. Płońska-Gościniak E, Suwalski P, Bartuś S, et al. Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol. 2020; 78(5): 498–507.
  31. Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012; 14(8): 931–938.
  32. Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail. 2019; 7(11): 945–955.
  33. Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2019; 40(5): 466–472.
  34. Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018; 54(3): 460–466.
  35. Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol. 2018; 71(1): 25–36.